EVARREST™ Fibrin Sealant Patch Post-Market Study

Clinical trial NCT01902459 · COMPLETED

Trial details

NCT number: NCT01902459
Sponsor: Ethicon, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hemorrhage Soft Tissue Bleeding

Start date: 2013-07-01
Primary completion: 2015-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.